NANTES, FRANCE--(Marketwire - October 17, 2007) - October 17th, 2007 - Vivalis (Euronext : VLS) announces today having granted rights to SANOFI- AVENTIS to evaluate EBx® cell lines, cell substrates derived from avian embryonic stem cells, for the production of monoclonal antibodies.
